Dermatology acquisitions remain steady despite broader healthcare deal declines

Dermatology mergers and acquisitions held steady in the first half of 2026, defying a 16 percent year-over-year decline in broader healthcare services deal activity. According to a market report by TUSK Practice Sales, which cited PitchBook data of 79 reported healthcare services deals in Q1 2026, buyers are competing heavily for well-run practices that generate 500,000 dollars or more in EBITDA. This transaction activity is expected to remain steady, particularly since at least 25 private equity-backed dermatology platforms have been held for five or more years and must pursue recapitalization events soon. The broader sector remains fundamentally strong, with the U.S. dermatological services market projected to grow from 63 billion dollars in 2023 to 128 billion dollars by 2033 at a 7.3 percent compound annual growth rate. However, regulatory shifts are altering where deals happen. Legislative measures targeting corporate practice ownership, including Oregon's SB 951 and California's SB 351, are steering buyers away from restrictive environments and toward states with less red tape. For owners evaluating their long-term transition plans, monitoring these local policy changes will be as vital to securing a premium valuation as driving clinical volume.

Source: PR Newswire, https://www.prnewswire.com/news-releases/tusk-practice-sales-releases-q3-2026-dermatology-ma-market-report-302198083.html